Wenzel C - Search Results

1

Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R; ABCSG-14. Steger GG, et al. Among authors: wenzel c. J Clin Oncol. 2007 May 20;25(15):2012-8. doi: 10.1200/JCO.2006.09.1777. J Clin Oncol. 2007. PMID: 17513805 Clinical Trial.

2

Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor.

Wenzel C, Locker GJ, Schmidinger M, Rudas M, Taucher S, Gnant MF, Jakesz R, Steger GG. Wenzel C, et al. Anticancer Drugs. 2002 Jan;13(1):67-74. doi: 10.1097/00001813-200201000-00008. Anticancer Drugs. 2002. PMID: 11914643 Clinical Trial.

3

Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

Taucher S, Rudas M, Mader RM, Gnant M, Sporn E, Dubsky P, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger GG, Mittlböck M, Jakesz R. Taucher S, et al. Among authors: wenzel c. Breast Cancer Res Treat. 2003 Dec;82(3):207-13. doi: 10.1023/B:BREA.0000004378.15859.51. Breast Cancer Res Treat. 2003. PMID: 14703068

4

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study.

Wenzel C, Hussian D, Bartsch R, Pluschnig U, Locker GJ, Rudas M, Gnant MF, Jakesz R, Zielinkski CC, Steger GG. Wenzel C, et al. J Cancer Res Clin Oncol. 2004 Jul;130(7):400-4. doi: 10.1007/s00432-004-0559-6. J Cancer Res Clin Oncol. 2004. PMID: 15168107 Clinical Trial.

5

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

Wenzel C, Bartsch R, Hussian D, Pluschnig U, Altorjai G, Zielinski CC, Lang A, Haid A, Jakesz R, Gnant M, Steger GG. Wenzel C, et al. Breast Cancer Res Treat. 2007 Jul;104(1):109-14. doi: 10.1007/s10549-006-9397-3. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061042 Clinical Trial.

6

Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment.

Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Mader RM, Gnant M, Jakesz R, Rudas M, Zielinski CC, Steger GG. Bartsch R, et al. Among authors: wenzel c. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4435-9. doi: 10.1158/1078-0432.CCR-06-3050. Clin Cancer Res. 2007. PMID: 17671127

7

Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.

Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Rudas M, Mader RM, Gnant M, Zielinski CC, Steger GG. Bartsch R, et al. Among authors: wenzel c. J Clin Oncol. 2007 Sep 1;25(25):3853-8. doi: 10.1200/JCO.2007.11.9776. Epub 2007 Aug 6. J Clin Oncol. 2007. PMID: 17679724 Clinical Trial.

8

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.

Wenzel C, Locker GJ, Pluschnig U, Zielinski CC, Rudas M, Oberhuber G, Gnant MF, Taucher S, Jakesz R, Steger GG. Wenzel C, et al. Cancer Chemother Pharmacol. 2002 Aug;50(2):155-9. doi: 10.1007/s00280-002-0476-9. Epub 2002 Jun 7. Cancer Chemother Pharmacol. 2002. PMID: 12172982 Clinical Trial.

9

Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer.

Wenzel C, Bartsch R, Locker GJ, Hussian D, Pluschnig U, Sevelda U, Gnant MF, Jakesz R, Zielinski CC, Steger GG. Wenzel C, et al. Anticancer Drugs. 2005 Apr;16(4):441-5. doi: 10.1097/00001813-200504000-00011. Anticancer Drugs. 2005. PMID: 15746581 Clinical Trial.

10

Preoperative second-line chemotherapy induces objective responses in primary breast cancer.

Wenzel C, Locker GJ, Bartsch R, Pluschnig U, Hussian D, Zielinski CC, Rudas M, Gnant MF, Jakesz R, Steger GG. Wenzel C, et al. Wien Klin Wochenschr. 2005 Jan;117(1-2):48-52. doi: 10.1007/s00508-004-0282-y. Wien Klin Wochenschr. 2005. PMID: 15986591 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters